ArticleCancer drug resistance (Alhambra, Calif.)2021

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome.

Wanqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.